
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
24 November 2003:
Ernst & Young Entrepreneur of the Year
25 June 2003:
Zealand Pharma and Aventis Sign Licensing Deal
1 May 2003:
Zealand Pharma and Wyeth Enter Collaboration for Cardiovascular Therapy
27 March 2003:
Zealand Pharma and Elan Terminate Betacure Joint Venture. Zealand Pharma raises €5 million from existing investors